These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Postconditioning with a CpG containing oligodeoxynucleotide ameliorates myocardial infarction in a murine closed-chest model. Kim SC; Wu S; Fang X; Neumann J; Eichhorn L; Schleifer G; Boehm O; Meyer R; Frede S; Hoeft A; Baumgarten G; Knuefermann P Life Sci; 2014 Dec; 119(1-2):1-8. PubMed ID: 25445440 [TBL] [Abstract][Full Text] [Related]
4. CpG postconditioning after reperfused myocardial infarction is associated with modulated inflammation, less apoptosis, and better left ventricular function. Duerr GD; Wu S; Schneider ML; Marggraf V; Weisheit CK; Velten M; Verfuerth L; Frede S; Boehm O; Treede H; Dewald O; Baumgarten G; Kim SC Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H995-H1007. PubMed ID: 32857588 [TBL] [Abstract][Full Text] [Related]
5. In vivo TLR9 inhibition attenuates CpG-induced myocardial dysfunction. Boehm O; Markowski P; van der Giet M; Gielen V; Kokalova A; Brill C; Hoeft A; Baumgarten G; Meyer R; Knuefermann P Mediators Inflamm; 2013; 2013():217297. PubMed ID: 23690658 [TBL] [Abstract][Full Text] [Related]
6. Remote ischemic preconditioning confers late protection against myocardial ischemia-reperfusion injury in mice by upregulating interleukin-10. Cai ZP; Parajuli N; Zheng X; Becker L Basic Res Cardiol; 2012 Jul; 107(4):277. PubMed ID: 22752341 [TBL] [Abstract][Full Text] [Related]
7. Cpg-ODN, a TLR9 Agonist, Aggravates Myocardial Ischemia/Reperfusion Injury by Activation of TLR9-P38 MAPK Signaling. Xie L; He S; Kong N; Zhu Y; Tang Y; Li J; Liu Z; Liu J; Gong J Cell Physiol Biochem; 2018; 47(4):1389-1398. PubMed ID: 29929196 [TBL] [Abstract][Full Text] [Related]
9. CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling. Cao Z; Ren D; Ha T; Liu L; Wang X; Kalbfleisch J; Gao X; Kao R; Williams D; Li C Biochim Biophys Acta; 2013 Jan; 1832(1):96-104. PubMed ID: 22917564 [TBL] [Abstract][Full Text] [Related]
10. Nasal vaccination with troponin reduces troponin specific T-cell responses and improves heart function in myocardial ischemia-reperfusion injury. Frenkel D; Pachori AS; Zhang L; Dembinsky-Vaknin A; Farfara D; Petrovic-Stojkovic S; Dzau VJ; Weiner HL Int Immunol; 2009 Jul; 21(7):817-29. PubMed ID: 19515797 [TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor plays an essential role in ischemic preconditioning-mediated cardioprotection. Ruze A; Chen BD; Liu F; Chen XC; Gai MT; Li XM; Ma YT; Du XJ; Yang YN; Gao XM Clin Sci (Lond); 2019 Mar; 133(5):665-680. PubMed ID: 30804219 [TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 9-activation during onset of myocardial ischemia does not influence infarct extension. Ohm IK; Gao E; Belland Olsen M; Alfsnes K; Bliksøen M; Øgaard J; Ranheim T; Nymo SH; Holmen YD; Aukrust P; Yndestad A; Vinge LE PLoS One; 2014; 9(8):e104407. PubMed ID: 25126943 [TBL] [Abstract][Full Text] [Related]
13. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. Frangogiannis NG; Mendoza LH; Lindsey ML; Ballantyne CM; Michael LH; Smith CW; Entman ML J Immunol; 2000 Sep; 165(5):2798-808. PubMed ID: 10946312 [TBL] [Abstract][Full Text] [Related]
14. N,N-dimethylsphingosine attenuates myocardial ischemia-reperfusion injury by recruiting regulatory T cells through PI3K/Akt pathway in mice. Fang J; Hu F; Ke D; Yan Y; Liao Z; Yuan X; Wu L; Jiang Q; Chen L Basic Res Cardiol; 2016 May; 111(3):32. PubMed ID: 27048490 [TBL] [Abstract][Full Text] [Related]
15. Cytidine-phosphate-guanosine oligodeoxynucleotides in combination with CD40 ligand decrease periodontal inflammation and alveolar bone loss in a TLR9-independent manner. Zhao Q; Hu Y; Deng S; Yu P; Chen B; Wang Z; Han X J Appl Oral Sci; 2018; 26():e20170451. PubMed ID: 29791566 [TBL] [Abstract][Full Text] [Related]
16. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429 [TBL] [Abstract][Full Text] [Related]
17. [Protective effect of fosinopril sodium pretreatment combined with ischemic postconditioning on rat heart underwent myocardial ischemia/reperfusion injury]. Zhang DW; Zhang L; Liu JG; Wang CL; Shi DZ; Chen KJ Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Jul; 38(7):633-7. PubMed ID: 21055289 [TBL] [Abstract][Full Text] [Related]
18. NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective. Sandanger Ø; Gao E; Ranheim T; Bliksøen M; Kaasbøll OJ; Alfsnes K; Nymo SH; Rashidi A; Ohm IK; Attramadal H; Aukrust P; Vinge LE; Yndestad A Biochem Biophys Res Commun; 2016 Jan; 469(4):1012-20. PubMed ID: 26706279 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 mediates exercise preconditioning against myocardial ischemia reperfusion injury. McGinnis GR; Ballmann C; Peters B; Nanayakkara G; Roberts M; Amin R; Quindry JC Am J Physiol Heart Circ Physiol; 2015 Jun; 308(11):H1423-33. PubMed ID: 25820396 [TBL] [Abstract][Full Text] [Related]